收入
成本
利润
| Item | Category | Value | YoY |
|---|---|---|---|
| Net sales | revenue | 1.08B | 7.90% |
| Operating income (loss) | profit | 31.00M | -83.23% |
| Gross profit | profit | 735.40M | 8.29% |
| Cost of sales | cost | 346.10M | 7.09% |
| Aggregate | revenue | 766.40M | |
| Selling, general and administrative expense | cost | 676.20M | 69.47% |
| Amortization of intangibles | cost | 47.70M | -4.22% |
| Research and development expense | cost | 42.50M | -6.59% |
| Segment | Value | YoY |
|---|---|---|
| Coopervision | 723.50M | 8.05% |
| Coopersurgical | 358.00M | 7.60% |
| Segment | Value | YoY |
|---|---|---|
| UNITED STATES | 547.80M | 6.33% |
| Europe | 341.60M | 17.03% |
| Rest Of World, Excluding United States And Europe | 192.10M | -1.59% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Total inventories | assets | 896.40M | |
| Trade accounts receivable, net of allowance for credit losses of $69.1 at april 30, 2026, and $51.9 at october 31, 2025 | assets | 809.20M | |
| Prepaid expense and other current assets | assets | 455.40M | |
| Cash and cash equivalents | assets | 138.80M | |
| Total current assets | assets | 2.30B | |
| Goodwill | assets | 3.89B | |
| Property, plant and equipment, net | assets | 2.13B | |
| Deferred tax assets | assets | 1.99B | |
| Other intangibles, net (note 3) | assets | 1.49B | |
| Other assets | assets | 672.80M | |
| Total assets | assets | 12.48B | |
| Stockholders’ equity (note 8) | liabilities | 8.24B | |
| Total liabilities | liabilities | 4.24B | |
| Noncontrolling interests | liabilities | 200000 | |
| Treasury stock, common, value | equity | 1.10B | |
| Accumulated other comprehensive income (loss), net of tax | equity | 363.20M | |
| Total cooper stockholders’ equity | equity | 8.24B | |
| Long-term debt (note 4) | liabilities | 1.86B | |
| Total current liabilities | liabilities | 1.80B | |
| Other liabilities | liabilities | 266.40M | |
| Deferred revenue | liabilities | 208.80M | |
| Deferred tax liabilities | liabilities | 96.40M | |
| Long-term tax payable | liabilities | 5.60M | |
| Aggregate | equity | 9.70B | |
| Short-term debt (note 4) | liabilities | 598.90M | |
| Other current liabilities | liabilities | 353.90M | |
| Accrued litigation liability (note 9) | liabilities | 324.80M | |
| Accounts payable | liabilities | 233.30M | |
| Employee compensation and benefits | liabilities | 165.90M | |
| Deferred revenue (note 2) | liabilities | 127.90M | |
| Retained earnings | equity | 7.70B | |
| Additional paid-in capital | equity | 1.98B | |
| Common stock, value, issued | equity | 21.80M |
| Item | Value |
|---|---|
| Depreciation and amortization | 190.90M |
| Deferred income taxes | 87.10M |
| Other noncash income (expense) | 57.80M |
| Adjustment to reconcile net income to cash provided by (used in) operating activity, increase (decrease) in operating capital | 55.50M |
| Net income | 52.90M |
| Business combination, contingent consideration arrangements, settlement amount of contingent consideration, liability | -500000 |
| Item | Value |
|---|---|
| Payments to acquire businesses and assets, net of cash acquired, and other | -4.30M |
| Payments to acquire property, plant, and equipment | -188.60M |
| Item | Value |
|---|---|
| Proceeds from long-term debt, net of issuance costs | 1.73B |
| Issuance of common stock for employee stock purchase plan | 3.90M |
| Net proceeds from short-term debt | 2.00M |
| Payment for contingent consideration liability, financing activities | -1.30M |
| Proceeds from (payments of) share-based arrangement | -28.70M |
| Payments to acquire business, gross, installments | -44.50M |
| Payments for repurchase of common stock | -108.00M |
| Repayments of long-term debt | -1.78B |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 110.60M |
| Cash and cash equivalents, end of period | 139.00M |
快速穿透 10-K/10-Q 复杂数据。通过利润表及资产负债表桑基图,与现金流量表瀑布图,一站式洞悉企业财务流向。
在左侧搜索公司并选择一份报告。
申请股票支持